← Back to Search

Smoke-Free Home Program for Smoking Cessation

N/A

Recruiting

Led By Maya Vijayaraghavan, MD, MAS

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 years or older

Ability to understand study procedures and to comply with them for the entire length of the study

Must not have

Contraindication to any study-related procedure or assessment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will examine the impact of a smoke-free home intervention on reducing tobacco-caused disparities among 400 homeless residents in 20 sites across the San Francisco Bay Area.

Who is the study for?

This trial is for English-speaking adults who currently smoke in their homes, have smoked at least 100 cigarettes in their lifetime, and are living in permanent supportive housing. They should expect to stay there for at least a year and be able to follow the study's procedures.

What is being tested?

The study tests a smoke-free home intervention that includes resident counseling and staff training. It aims to encourage voluntary adoption of smoke-free homes among residents of permanent supportive housing sites across the San Francisco Bay Area.

What are the potential side effects?

Since this trial involves behavioral interventions like counseling and education rather than medications, traditional side effects are not expected. However, participants may experience stress or discomfort discussing smoking habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I understand and can follow the study's procedures.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have no health issues preventing me from undergoing study procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Proportion of participants who adopt a smoke-free home voluntarily

Secondary study objectives

Proportion of participants who achieve abstinence

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Wait-List Control (Usual Care) then crossover to Smoke-free home PSH resident interventionExperimental Treatment1 Intervention

The current standard of care includes no interventions for smoke-free home adoption or referrals to smoking cessation resources. Wait-list group receives Smoke-Free Home (SFH) intervention after intervention group complete 6-month follow-up

Group II: Smoke-free home permanent supportive housing (PSH) resident intervention + Staff InterventionExperimental Treatment2 Interventions

Study staff will deliver a one hour, one-on-one counseling to PSH residents that includes: (1) a step-by-step guide on how to voluntarily adopt a smoke-free home, (2) information on second hand smoke (SHS) and third-hand smoke, alternative combustible tobacco and nicotine product use, cannabis-tobacco co-use, effects of SHS on kids and pets,(3) a worksheet on calculating personal costs related to tobacco use, and (4) pledges to designate one's home smoke-free. At follow-up assessments, the study team will ask participants whether they had a chance to view the intervention materials in between visits and will offer an opportunity for participants to discuss conflicts that they had experienced around smoke-free home adoption and will provide strategies to address these roadblocks.

0 / 3Eligibility criteria met